2024. Innovative Hybrid Compounds Targeting Tuberculosis: Development, Characterization and Bioefficacy analysis of 6-substituted-2-Chloroquinoline-3-Carbaldehyde Hydrazide Ester derivatives. International Journal of Pharmaceutical Sciences and Drug Research. 16, 3 (May 2024), 378–386. DOI:https://doi.org/10.25004/IJPSDR.2024.160309.